MED-X has filed financial statements for 2 reporting years in the Polish National Court Register (KRS 0001136708), covering 2024–2025. The dashboard below shows the income statement, balance sheet, profitability ratios, valuation indicators and a multi-year comparison against the company's industry benchmark.

Headline figures for the most recent reported year (2025): net revenue 2,435,188 PLN, net profit 282,228 PLN, total assets 1,093,079 PLN and equity 462,714 PLN. Use the chart toolbar to switch between absolute amounts and indexed series, or to jump straight into the per-year sprawozdanie finansowe.

Derived metrics include ROE, ROA, net and operating margin, the current ratio and the cash ratio, debt-to-equity and asset turnover. Each ratio is plotted alongside the median for MED-X's PKD activity class, so reading whether the company is above or below the industry takes one glance instead of a side-by-side calculation.